Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Impella ECP Early Feasibility Study

NCT: NCT04477603 · ACTIVE_NOT_RECRUITING

NCT IDNCT04477603
StatusACTIVE_NOT_RECRUITING
Start Date2020-10-09
Completion2026-10-31
SponsorAbiomed Inc. (INDUSTRY)
First posted
Last updated

Brief Summary

The Impella ECP EFS is a prospective, multicenter, single-arm, feasibility study evaluating the safety of the Impella ECP device in adult patients undergoing an elective or urgent high-risk percutaneous coronary intervention.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑